In8Bio Inc (INAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,217 | 13,015 | 21,282 | 12,854 | 16,993 |
| TOTAL | $12,682 | $15,755 | $24,625 | $16,549 | $19,465 |
| Non-Current Assets | |||||
| PPE Net | 3,112 | 3,325 | 3,514 | 3,738 | 3,977 |
| Other Non-Current Assets | 6,702 | 6,469 | 5,570 | 5,921 | 6,276 |
| TOTAL | $9,814 | $9,794 | $9,084 | $9,659 | $10,253 |
| Total Assets | $22,496 | $25,549 | $33,709 | $26,208 | $29,718 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,444 | 1,413 | 924 | 748 | 585 |
| Accrued Expenses | 1,533 | 895 | 2,955 | 2,440 | 1,674 |
| TOTAL | $4,759 | $3,844 | $5,393 | $4,686 | $3,781 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 3,590 | 3,828 | 2,854 | 3,069 | 3,277 |
| TOTAL | $4,116 | $4,179 | $3,379 | $3,764 | $4,138 |
| Total Liabilities | $8,875 | $8,023 | $8,772 | $8,450 | $7,919 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,558 | 1,469 | 1,441 | 1,065 | 1,052 |
| Common Shares | 5 | 4 | 4 | 4 | 4 |
| Retained earnings | -108,410 | -99,781 | -91,219 | -83,621 | -76,452 |
| TOTAL | $13,621 | $17,526 | $24,937 | $17,758 | $21,799 |
| Total Liabilities And Equity | $22,496 | $25,549 | $33,709 | $26,208 | $29,718 |